Prenetics Global Limited Announces $48 Million Equity Offering

Prenetics Global Limited (NASDAQ: PRE) announced the successful pricing of a best efforts public offering on October 27, 2025. The offering includes 2,992,596 Class A ordinary shares, Class A Common Warrants, and Class B Common Warrants at a combined offering price of $16.08 per share. The gross proceeds are expected to be approximately $48.0 million, before deducting placement agent fees and offering expenses. The Class A Common Warrants have an exercise price of $24.12 per share, and the Class B Common Warrants have an exercise price of $32.16 per share. Both warrants are immediately exercisable for five years. The proceeds will be used for the global expansion of IM8 and the strategic accumulation of Bitcoin as part of the company's dual-pronged health and wealth strategy. The offering is expected to close on October 28, 2025, subject to customary closing conditions. Dominari Securities LLC acted as the sole placement agent for the offering.